The highly anticipated innovative Retatrutide 20mg device is gradually entering the market in the UK. As of now, access is controlled and primarily via specialist clinics participating in clinical programs. Despite a full, broad commercial rollout date remains tentative, initial reports that those eligible will be able to access the drug via specia